Mercury Poisoning Treatment Market Geographical Analysis,Outlook, Competitive Landscape and Forecasts to 2030

Mercury Poisoning Treatment Market: Introduction

Mercury poisoning due to exposure to mercury depends upon the type, dose, method, and duration of exposure. High-level exposure to methylmercury is known as Minamata disease. Long-term complications could include kidney problems and decreased intelligence. Symptoms could include muscle weakness, poor coordination, numbness in the hands and feet, skin rashes, anxiety, memory problems, trouble speaking, trouble hearing, or trouble seeing.

Key Drivers and Restraints of Global Mercury Poisoning Treatment Market

Rise in number of patients who avail mercury-containing dental amalgams drives the global mercury poisoning treatment market. All types of dental amalgams contain mercury, which partly is emitted as mercury vapor. All types of dental amalgams corrode after being placed in the oral cavity. According to the World Health Organization (WHO), the principal human exposure to mercury is from dental amalgams. The WHO also lists mercury as one of the top ten chemicals of major health concern. Even after the last mercury dental amalgam is placed, its toxic legacy will continue for decades because of its pervasive bioaccumulation in the environment.
However, limited availability of medicinal treatment options due to low prevalence of mercury toxicity restrains the global market.

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Mercury Poisoning Treatment Market Report

Dimercaptosuccinic Acid to Dominate Global Mercury Poisoning Treatment Market

In terms of drug type, the global mercury poisoning treatment market can be classified into dimercaprol, dimercaptosuccinic acid, D-pennicillamine, and others
Dimercaptosuccinic acid is administered orally or through IV injection. The adult dosage is 250 mg IV every 4 hours for the first 48 hours, then 250 mg IV every 6 hours for the second 48 hours, and next 250 mg IV every 8 hours. After IV administration, oral therapy may be started with 300 mg for 7 weeks. Duration of treatment depends on the concentration of mercury in blood and urine. Side effects are rare, but rash, nausea, and leucopenia may be observed.

Oral Segment to Witness Strong Growth

Based on route of administration, the global mercury poisoning treatment market can be bifurcated into oral and injectable
Majority of the mercury poisoning treatment drugs such as D-penicillamine and dimercaptosuccinic are administered orally, as oral administration has been found better than intraperitoneal injection

North America to Lead Global Mercury Poisoning Treatment Market

In terms of region, the global mercury poisoning treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
In terms of revenue, North America dominated the global mercury poisoning treatment market in 2019, followed by Europe. However, the market in Asia Pacific is expected to grow at the highest CAGR from 2020 to 2030.
According to a 2017 study comparing mercury levels among women of childbearing age in Asia Pacific revealed high traces of mercury in 96.0% of the women tested from Pacific communities who have high fish diets